A case report of persistent phrenic nerve injury following pulsed field ablation using a pentaspline catheter

本文报告了一例使用五角形导管进行脉冲场消融术后持续性膈神经损伤的病例。

阅读:1

Abstract

BACKGROUND: Pulsed field ablation (PFA) is an emerging non-thermal ablation modality for atrial fibrillation (AF), characterized by its myocardial selectivity and reduced risk of collateral damage to extracardiac structures such as the oesophagus and phrenic nerve (PN). While transient phrenic nerve injury (PNI) has been reported, persistent diaphragmatic paralysis remains exceedingly rare. CASE PRESENTATION: We report the case of a 49-year-old man with paroxysmal AF, refractory to medical therapy, who underwent pulmonary vein isolation using the FARAPULSE PFA system. The procedure was uneventful, and the patient was discharged the same day. However, he reported significant breathlessness on minimal exertion starting the day after the procedure. At his 6-week follow-up, physical examination revealed reduced air entry at the right lung base. A contrast-enhanced computed tomography chest confirmed an elevated right hemidiaphragm (9.0 cm posteriorly, 7.5 cm anteriorly), consistent with right PN palsy. The patient remained in sinus rhythm and asymptomatic from an arrhythmic standpoint, but continues to experience persistent dyspnoea. DISCUSSION: To our knowledge, this represents one of the early cases of persistent PN palsy following PFA with the FARAPULSE system. Although PFA is designed to target cardiomyocytes while sparing adjacent tissues selectively, proximity to the right PN-particularly near the right superior pulmonary vein-may still pose a risk. This case highlights the importance of procedural vigilance, including meticulous catheter positioning and careful consideration of nerve proximity. It highlights that persistent PNI, while rare, remains a potential complication of PFA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。